Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

28.42
+1.264.64%
Post-market: 28.13-0.2895-1.02%16:16 EDT
Volume:558.55K
Turnover:15.86M
Market Cap:36.33M
PE:- -
High:29.93
Open:27.63
Low:27.00
Close:27.16
52wk High:152.22
52wk Low:11.52
Shares:1.28M
Float Shares:1.28M
Volume Ratio:1.11
T/O Rate:43.69%
Dividend:3.85
Dividend Rate:13.54%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Anthropic CEO Urges Slowing The AI Model Race; Musk, Altman Voice Support

AI Industry Frontlines
·
Sep 13

Tempus AI to build multimodal whole-genome dataset for AI-driven healthcare

TIPRANKS
·
Sep 11

Tempus AI Launches Effort to Build 100,000 Whole-Genome Dataset Linked to Clinical Outcomes

Reuters
·
Sep 11

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

THOMSON REUTERS
·
Sep 11

Tempus AI, - General Availability of Dataset Planned for Mid-2027

THOMSON REUTERS
·
Sep 11

$1M → $7B ARR In 10Y! Databricks On Enterprise AI Moat

Bellwether Stocks Movement
·
Sep 11

Anthropic: 3 AI Economic Scenarios to 2030, 15% YoY Growth in Bull Case

AI Industry Frontlines
·
Sep 11

HSBC Says The AI Trade's Next Chapter Hinges On One Word: Monetization

Analyst Calls
·
Sep 10

Tempus AI awarded up to $9.5M from ARPA-H for autonomous AI in cardiology

TIPRANKS
·
Sep 10

Tempus AI Wins up to $9.5 Million ARPA-H Advocate Award for Autonomous Heart Failure Agent

Reuters
·
Sep 10

Tempus Secures up to $9.5 Million in Arpa-H Advocate Funding to Deploy First Autonomous AI in Cardiology

THOMSON REUTERS
·
Sep 10

Tempus AI Initiated at Neutral by UBS

Dow Jones
·
Sep 09

UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target

MT Newswires Live
·
Sep 09

Tempus AI Price Target Announced at $67.00/Share by Roth Capital

Dow Jones
·
Sep 08

Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target

MT Newswires Live
·
Sep 08

Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips

AI Industry Frontlines
·
Sep 08

Kospi Down 27%, Goldman Still Says 12,000: "The Market Is Underpricing This Cycle"

Analyst Calls
·
Sep 07

Tempus AI CEO Lefkofsky to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 04

The Cancer Vaccine Gold Rush Has Begun. so Has the Race for Picks and Shovels - Heard on the Street

Dow Jones
·
Sep 04

$15B Credit + $2T Valuation: Anthropic's IPO Ambition

AI Industry Frontlines
·
Sep 04